ArticleEuropean journal of nuclear medicine and molecular imaging2019

Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics.

Romain-David Seban et al.PubMed ↗Publisher ↗

No numbers read from the abstract.